143 related articles for article (PubMed ID: 38071211)
1. SOCS2 inhibits hepatoblastoma metastasis via downregulation of the JAK2/STAT5 signal pathway.
Lv Y; Xie X; Zou G; Kong M; Yang J; Chen J; Xiang B
Sci Rep; 2023 Dec; 13(1):21814. PubMed ID: 38071211
[TBL] [Abstract][Full Text] [Related]
2. SOCS2: inhibitor of JAK2V617F-mediated signal transduction.
Quentmeier H; Geffers R; Jost E; Macleod RA; Nagel S; Röhrs S; Romani J; Scherr M; Zaborski M; Drexler HG
Leukemia; 2008 Dec; 22(12):2169-75. PubMed ID: 18769447
[TBL] [Abstract][Full Text] [Related]
3. STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma.
Sen B; Peng S; Woods DM; Wistuba I; Bell D; El-Naggar AK; Lai SY; Johnson FM
Clin Cancer Res; 2012 Jan; 18(1):127-39. PubMed ID: 22090359
[TBL] [Abstract][Full Text] [Related]
4. Suppressor of cytokine signalling-2 controls hepatic gluconeogenesis and hyperglycemia by modulating JAK2/STAT5 signalling pathway.
Zhang X; Zhuang Y; Qin T; Chang M; Ji X; Wang N; Zhang Z; Zhou H; Wang Q; Li JZ
Metabolism; 2021 Sep; 122():154823. PubMed ID: 34197875
[TBL] [Abstract][Full Text] [Related]
5. miR-181b-5p/SOCS2/JAK2/STAT5 axis facilitates the metastasis of hepatoblastoma.
Lv Y; Xie X; Zou G; Kong M; Yang J; Chen J; Xiang B
Precis Clin Med; 2023 Dec; 6(4):pbad027. PubMed ID: 37955014
[TBL] [Abstract][Full Text] [Related]
6. t(8;9)(p22;p24)/PCM1-JAK2 activates SOCS2 and SOCS3 via STAT5.
Ehrentraut S; Nagel S; Scherr ME; Schneider B; Quentmeier H; Geffers R; Kaufmann M; Meyer C; Prochorec-Sobieszek M; Ketterling RP; Knudson RA; Feldman AL; Kadin ME; Drexler HG; MacLeod RA
PLoS One; 2013; 8(1):e53767. PubMed ID: 23372669
[TBL] [Abstract][Full Text] [Related]
7. IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma.
Peng HY; Jiang SS; Hsiao JR; Hsiao M; Hsu YM; Wu GH; Chang WM; Chang JY; Jin SL; Shiah SG
Mol Oncol; 2016 Jun; 10(6):895-909. PubMed ID: 27038552
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic downregulation of Socs2 contributes to mutant N-Ras-mediated hematopoietic dysregulation.
Jin X; Ng V; Zhao M; Liu L; Higashimoto T; Lee ZH; Chung J; Chen V; Ney G; Kandarpa M; Talpaz M; Li Q
Dis Model Mech; 2022 May; 15(5):. PubMed ID: 35352806
[TBL] [Abstract][Full Text] [Related]
9. Suppressor of Cytokine Signaling 2 Negatively Regulates NK Cell Differentiation by Inhibiting JAK2 Activity.
Kim WS; Kim MJ; Kim DO; Byun JE; Huy H; Song HY; Park YJ; Kim TD; Yoon SR; Choi EJ; Jung H; Choi I
Sci Rep; 2017 Apr; 7():46153. PubMed ID: 28383049
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signalling-2 limits IGF1R-mediated regulation of epithelial-mesenchymal transition in lung adenocarcinoma.
Zhou Y; Zhang Z; Wang N; Chen J; Zhang X; Guo M; John Zhong L; Wang Q
Cell Death Dis; 2018 Apr; 9(4):429. PubMed ID: 29559623
[TBL] [Abstract][Full Text] [Related]
11. LncRNA WDFY3-AS2 suppresses proliferation and invasion in oesophageal squamous cell carcinoma by regulating miR-2355-5p/SOCS2 axis.
Zhang Q; Guan F; Fan T; Li S; Ma S; Zhang Y; Guo W; Liu H
J Cell Mol Med; 2020 Jul; 24(14):8206-8220. PubMed ID: 32536038
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
[TBL] [Abstract][Full Text] [Related]
13. SOCS2 exacerbates myocardial injury induced by ischemia/reperfusion in diabetic mice and H9c2 cells through inhibiting the JAK-STAT-IGF-1 pathway.
Sheng M; Huang Z; Pan L; Yu M; Yi C; Teng L; He L; Gu C; Xu C; Li J
Life Sci; 2017 Nov; 188():101-109. PubMed ID: 28867579
[TBL] [Abstract][Full Text] [Related]
14. lncRNA TUG1 regulates angiogenesis via the miR‑204‑5p/JAK2/STAT3 axis in hepatoblastoma.
Yuan MX; Ji CY; Gao HQ; Sheng XY; Xie WX; Yin Q
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080023
[TBL] [Abstract][Full Text] [Related]
15. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.
Cui M; Sun J; Hou J; Fang T; Wang X; Ge C; Zhao F; Chen T; Xie H; Cui Y; Yao M; Li J; Li H
Tumour Biol; 2016 Oct; 37(10):13521-13531. PubMed ID: 27465557
[TBL] [Abstract][Full Text] [Related]
16. CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling.
Wang F; Wang X; Li J; Lv P; Han M; Li L; Chen Z; Dong L; Wang N; Gu Y
J Biomed Sci; 2021 Jan; 28(1):4. PubMed ID: 33397365
[TBL] [Abstract][Full Text] [Related]
17. MiR-920 and LSP1 co-regulate the growth and migration of glioblastoma cells by modulation of JAK2/STAT5 pathway.
Cong P; Hou HY; Wei W; Zhou Y; Yu XM
J Bioenerg Biomembr; 2020 Oct; 52(5):311-320. PubMed ID: 32770294
[TBL] [Abstract][Full Text] [Related]
18. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
[TBL] [Abstract][Full Text] [Related]
19. Intracellular matrix Gla protein promotes tumor progression by activating JAK2/STAT5 signaling in gastric cancer.
Wang M; Chen L; Chen Y; Wei R; Guo Q; Zhu S; Guo S; Zhu S; Zhang S; Min L
Mol Oncol; 2020 May; 14(5):1045-1058. PubMed ID: 32086862
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2.
Ren W; Wu S; Wu Y; Liu T; Zhao X; Li Y
Cell Death Dis; 2019 Apr; 10(5):333. PubMed ID: 30988277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
